Director of Target Validation & Translational Immunology

Eli Lilly and Company; Indianapolis (IN); Sur place; USD 153 000 - 264 000; Plein temps

Avantages offerts par ce poste

Company bonus

401(k) plan

Vacation benefits

Well-being benefits

Résumé du poste

Eli Lilly and Company is seeking a Director/Senior Director for New Target Validation within Discovery Immunology. The role guides biological strategy and translational readiness, coordinating across internal teams and external partners to advance validation through mechanistic discovery in human model systems.

The candidate will lead end-to-end validation strategy, develop innovative human systems, and integrate multimodal data to support robust decision-making and progression criteria.

Qualifications

• Ph.D. in Molecular Genetics and Immunology.
• 8-10 years of drug development experience in autoimmune diseases GA/RS? (asthma, atopic dermatitis, rheumatologic diseases).
• Strong interpersonal skills and the ability to make data-driven decisions and communicate with senior leadership.

Responsabilités

• Define and lead end-to-end strategy for new target validation across genetic perturbation and translational model design.
• Develop novel human systems for target validation (Organs-on-chip, IPSC, ex vivo models).
• Integrate multimodal profiling (imaging, transcriptomics, cytokines, proteomics) to strengthen disease relevance.
• Communicate workplans to drive scientific decision-making across multidisciplinary teams.
• Train discovery biologists in molecular designs and functional assays.
• Guide cross-functional project teams through influence in a matrixed organization.

Connaissances

Leadership

Communication

Cross-functional collaboration

Formation

Ph.D. in Molecular Genetics and Immunology

Description du poste

Eli Lilly and Company is seeking a Director/Senior Director for New Target Validation within Discovery Immunology. The role guides biological strategy and translational readiness, coordinating across internal teams and external partners to advance validation through mechanistic discovery in human model systems.

The candidate will lead end-to-end validation strategy, develop innovative human systems, and integrate multimodal data to support robust decision-making and progression criteria.